chr20-46049727-C-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_ModerateBP6_ModerateBP7BS1BS2
The NM_020708.5(SLC12A5):c.2118C>T(p.Ile706Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000912 in 1,604,404 control chromosomes in the GnomAD database, including 53 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
 Genomes: 𝑓 0.00053   (  5   hom.,  cov: 33) 
 Exomes 𝑓:  0.00095   (  48   hom.  ) 
Consequence
 SLC12A5
NM_020708.5 synonymous
NM_020708.5 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -1.45  
Publications
6 publications found 
Genes affected
 SLC12A5  (HGNC:13818):  (solute carrier family 12 member 5) K-Cl cotransporters are proteins that lower intracellular chloride concentrations below the electrochemical equilibrium potential. The protein encoded by this gene is an integral membrane K-Cl cotransporter that can function in either a net efflux or influx pathway, depending on the chemical concentration gradients of potassium and chloride. The encoded protein can act as a homomultimer, or as a heteromultimer with other K-Cl cotransporters, to maintain chloride homeostasis in neurons. Alternative splicing results in two transcript variants encoding different isoforms. [provided by RefSeq, Sep 2008] 
SLC12A5 Gene-Disease associations (from GenCC):
- developmental and epileptic encephalopathy, 34Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Ambry Genetics
- epilepsy of infancy with migrating focal seizuresInheritance: AR Classification: STRONG Submitted by: G2P
- malignant migrating partial seizures of infancyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, idiopathic generalized, susceptibility to, 14Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Illumina, Ambry Genetics
- genetic developmental and epileptic encephalopathyInheritance: AR Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.3). 
BP6
Variant 20-46049727-C-T is Benign according to our data. Variant chr20-46049727-C-T is described in ClinVar as Benign. ClinVar VariationId is 542325.Status of the report is criteria_provided_single_submitter, 1 stars. 
BP7
Synonymous conserved (PhyloP=-1.45 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000532 (81/152296) while in subpopulation EAS AF = 0.015 (78/5192). AF 95% confidence interval is 0.0123. There are 5 homozygotes in GnomAd4. There are 44 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check. 
BS2
High Homozygotes in GnomAd4 at 5 AR,AD gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.000539  AC: 82AN: 152178Hom.:  5  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
82
AN: 
152178
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.000228  AC: 53AN: 232348 AF XY:  0.000176   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
53
AN: 
232348
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.000952  AC: 1383AN: 1452108Hom.:  48  Cov.: 34 AF XY:  0.000903  AC XY: 651AN XY: 721014 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
1383
AN: 
1452108
Hom.: 
Cov.: 
34
 AF XY: 
AC XY: 
651
AN XY: 
721014
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
33446
American (AMR) 
 AF: 
AC: 
1
AN: 
42848
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
25776
East Asian (EAS) 
 AF: 
AC: 
1341
AN: 
39414
South Asian (SAS) 
 AF: 
AC: 
1
AN: 
83664
European-Finnish (FIN) 
 AF: 
AC: 
4
AN: 
52880
Middle Eastern (MID) 
 AF: 
AC: 
3
AN: 
5752
European-Non Finnish (NFE) 
 AF: 
AC: 
14
AN: 
1108208
Other (OTH) 
 AF: 
AC: 
19
AN: 
60120
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.488 
Heterozygous variant carriers
 0 
 76 
 152 
 229 
 305 
 381 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 20 
 40 
 60 
 80 
 100 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.000532  AC: 81AN: 152296Hom.:  5  Cov.: 33 AF XY:  0.000591  AC XY: 44AN XY: 74476 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
81
AN: 
152296
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
44
AN XY: 
74476
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
41552
American (AMR) 
 AF: 
AC: 
0
AN: 
15300
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3468
East Asian (EAS) 
 AF: 
AC: 
78
AN: 
5192
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4822
European-Finnish (FIN) 
 AF: 
AC: 
1
AN: 
10622
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
2
AN: 
68022
Other (OTH) 
 AF: 
AC: 
0
AN: 
2112
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.470 
Heterozygous variant carriers
 0 
 6 
 11 
 17 
 22 
 28 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
8
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
Developmental and epileptic encephalopathy, 34    Benign:1 
Jan 25, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.